Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1973 1
1975 1
1976 4
1977 3
1978 3
1979 3
1980 1
1981 2
1982 5
1984 4
1985 2
1986 3
1987 2
1989 6
1990 1
1991 1
1992 5
1993 10
1994 5
1995 8
1996 12
1997 11
1998 13
1999 15
2000 13
2001 9
2002 15
2003 19
2004 18
2005 12
2006 14
2007 25
2008 24
2009 22
2010 17
2011 20
2012 21
2013 21
2014 18
2015 15
2016 15
2017 16
2018 15
2019 8
2020 14
2021 22
2022 8
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
Modeling Viral Spread.
Graw F, Perelson AS. Graw F, et al. Among authors: perelson as. Annu Rev Virol. 2016 Sep 29;3(1):555-572. doi: 10.1146/annurev-virology-110615-042249. Epub 2016 Aug 31. Annu Rev Virol. 2016. PMID: 27618637 Free PMC article. Review.
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.
McMyn NF, Varriale J, Fray EJ, Zitzmann C, MacLeod H, Lai J, Singhal A, Moskovljevic M, Garcia MA, Lopez BM, Hariharan V, Rhodehouse K, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM. McMyn NF, et al. Among authors: perelson as. J Clin Invest. 2023 Sep 1;133(17):e171554. doi: 10.1172/JCI171554. J Clin Invest. 2023. PMID: 37463049 Free PMC article.
Continuous and discrete modeling of HIV-1 decline on therapy.
Akın E, Yeni G, Perelson AS. Akın E, et al. Among authors: perelson as. J Math Biol. 2020 Jul;81(1):1-24. doi: 10.1007/s00285-020-01492-z. Epub 2020 Jun 2. J Math Biol. 2020. PMID: 32488570 Free PMC article.
Influenza A virus infection kinetics: quantitative data and models.
Smith AM, Perelson AS. Smith AM, et al. Among authors: perelson as. Wiley Interdiscip Rev Syst Biol Med. 2011 Jul-Aug;3(4):429-45. doi: 10.1002/wsbm.129. Epub 2010 Dec 31. Wiley Interdiscip Rev Syst Biol Med. 2011. PMID: 21197654 Free PMC article. Review.
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques.
Dashti A, Sukkestad S, Horner AM, Neja M, Siddiqi Z, Waller C, Goldy J, Monroe D, Lin A, Schoof N, Singh V, Mavigner M, Lifson JD, Deleage C, Tuyishime M, Falcinelli SD, King HAD, Ke R, Mason RD, Archin NM, Dunham RM, Safrit JT, Jean S, Perelson AS, Margolis DM, Ferrari G, Roederer M, Silvestri G, Chahroudi A. Dashti A, et al. Among authors: perelson as. Nat Med. 2023 Oct;29(10):2535-2546. doi: 10.1038/s41591-023-02570-7. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783968 Free PMC article.
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Stephenson KE, Julg B, Tan CS, Zash R, Walsh SR, Rolle CP, Monczor AN, Lupo S, Gelderblom HC, Ansel JL, Kanjilal DG, Maxfield LF, Nkolola J, Borducchi EN, Abbink P, Liu J, Peter L, Chandrashekar A, Nityanandam R, Lin Z, Setaro A, Sapiente J, Chen Z, Sunner L, Cassidy T, Bennett C, Sato A, Mayer B, Perelson AS, deCamp A, Priddy FH, Wagh K, Giorgi EE, Yates NL, Arduino RC, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH. Stephenson KE, et al. Among authors: perelson as. Nat Med. 2021 Oct;27(10):1718-1724. doi: 10.1038/s41591-021-01509-0. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621054 Free PMC article. Clinical Trial.
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial.
Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W; ACTIV-2/A5401 Study Team. Jagannathan P, et al. EClinicalMedicine. 2023 Oct 6;65:102250. doi: 10.1016/j.eclinm.2023.102250. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37855026 Free PMC article.
510 results